140 related articles for article (PubMed ID: 61095)
21. [Schizophrenia].
Guilmot PH
Brux Med; 1972 Nov; 52(11):749-53. PubMed ID: 4654572
[No Abstract] [Full Text] [Related]
22. [Enzymologic and chemico-clinical findings in schizophrenic syndromes].
Rizzoli AA; Galzigna L
Quad Sclavo Diagn; 1972 Mar; 8(1):208-15. PubMed ID: 4268408
[No Abstract] [Full Text] [Related]
23. Is schizophrenia an autoimmune disease? A review.
Knight JG
Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):395-403. PubMed ID: 6390022
[TBL] [Abstract][Full Text] [Related]
24. Medical hazards of aerosols. 1.
Bernstein IL
Postgrad Med; 1972 Dec; 52(6):62-8. PubMed ID: 4117898
[No Abstract] [Full Text] [Related]
25. [Research into the biochemical bases of schizophrenic syndromes: a review].
Laplante M; St-Laurent J
Union Med Can; 1973 Nov; 102(11):2267-78. PubMed ID: 4134633
[No Abstract] [Full Text] [Related]
26. On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias.
Ban TA
Psychopharmacol Bull; 1969 Jul; 5(3):5-20. PubMed ID: 4906584
[No Abstract] [Full Text] [Related]
27. The role of aminochromes in ultraweak luminescence accompanying oxidative metabolism of catecholamines in model systems in vitro.
Slawinska D; Slawinski J
Physiol Chem Phys Med NMR; 1991; 23(4):247-60. PubMed ID: 1812504
[TBL] [Abstract][Full Text] [Related]
28. [Biological-molecular trend in psychiatry].
Bilikiewicz A
Pol Tyg Lek; 1978 Jun; 33(26):1046-50. PubMed ID: 704404
[No Abstract] [Full Text] [Related]
29. The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
Wender PH
J Nerv Ment Dis; 1972 Jul; 155(1):55-71. PubMed ID: 4402515
[No Abstract] [Full Text] [Related]
30. On the relationship of adrenaline and its oxidation products to schizophrenia.
FELDSTEIN A
Am J Psychiatry; 1959 Nov; 116():454-6. PubMed ID: 13822066
[No Abstract] [Full Text] [Related]
31. [Recent progresses in the biology of schizophrenia].
Bonvalot T; Zarifian E
Rev Prat; 1992 May; 42(9):1139-43. PubMed ID: 1353900
[TBL] [Abstract][Full Text] [Related]
32. Implications of catecholamine systems of the brain in schizophrenia.
Matthysse S
Res Publ Assoc Res Nerv Ment Dis; 1974; 53():305-15. PubMed ID: 4155111
[No Abstract] [Full Text] [Related]
33. [Inborn errors of metabolism and neurotransmitters].
Mori A
Nihon Rinsho; 1978; 36(1):52-7. PubMed ID: 24765
[No Abstract] [Full Text] [Related]
34. Schizophrenia.
Huxley J; Mayr E; Osmond H
Nature; 1965 Jun; 206(989):1112. PubMed ID: 5866142
[No Abstract] [Full Text] [Related]
35. [Viral hypothesis of schizophrenia. Critical reflections].
Di Costanzo E; Schifano F
G Clin Med; 1990 May; 71(5):361-3, 366. PubMed ID: 2369994
[No Abstract] [Full Text] [Related]
36. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.
Baez S; Segura-Aguilar J; Widersten M; Johansson AS; Mannervik B
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):25-8. PubMed ID: 9164836
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical approaches to mental diseases].
Henry MP
Bord Med; 1972 Mar; 5(5):455-69. PubMed ID: 5071670
[No Abstract] [Full Text] [Related]
38. [Studies of the significance of disturbances in the metabolism of copper, ceruloplasmin and ascorbic acid in the pathogenesis of schizophrenia].
Puzyński S
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1969; 14():99-162. PubMed ID: 4989450
[No Abstract] [Full Text] [Related]
39. A further study of catecholamine omicron-methylation in schizophrenia.
Wagner AF; Cirillo VJ; Meisinger MA; Ormond RE; Kuehl FA; Brink NG
Nature; 1966 Aug; 211(5049):604-5. PubMed ID: 5968726
[No Abstract] [Full Text] [Related]
40. Is schizophrenia a viral or immunologic disorder?
DeLisi LE; Crow TJ
Psychiatr Clin North Am; 1986 Mar; 9(1):115-32. PubMed ID: 3083405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
